Shares of Bruker BioSciences (NASDAQ: [[ticker:BRKR]]), a Billerica, MA-based scientific instruments maker, are climbing on yesterday’s announcement that the firm will acquire the Bruker BioSpin Group, which develops magnetic resonance core technology, for $914 million in cash and stock. The resulting company, which will be called Bruker Corporation, is projected to have more than 3,700 employees and 2007 pro forma revenue upwards of $900 million. Bruker BioSciences closed today at $12.15, up 31 percent from Friday’s close of $9.29.
Author: Rebecca Zacks
Rebecca is Xconomy's co-founder. She was previously the managing editor of Physician's First Watch, a daily e-newsletter from the publishers of New England Journal of Medicine. Before helping launch First Watch, she spent a decade covering innovation for Technology Review, Scientific American, and Discover Magazine's TV show. In 2005-2006 she was a Knight Science Journalism Fellow at MIT. Rebecca holds a bachelor's degree in biology from Brown University and a master's in science journalism from Boston University.
View all posts by Rebecca Zacks
